SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000921895-19-003085
Filing Date
2019-12-27
Accepted
2019-12-27 16:32:04
Documents
3

Document Format Files

Seq Description Document Type Size
1 sc13da206922012_12272019.htm SC 13D/A 49179
2 ex993to13da206922012_122719.htm EX-99.3 52073
3 ex994to13da206922012_122719.htm EX-99.4 43037
  Complete submission text file 0000921895-19-003085.txt   145674
Mailing Address 611 SOUTH FORT HARRISON AVE SUITE 306 CLEARWATER FL 33756
Business Address
DUGGAN ROBERT W (Filed by) CIK: 0001055919 (see all company filings)

Type: SC 13D/A

Mailing Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB
Business Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB 44-123-544-3939
Summit Therapeutics plc (Subject) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0131
Type: SC 13D/A | Act: 34 | File No.: 005-88759 | Film No.: 191313969
SIC: 2834 Pharmaceutical Preparations